MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on Blue Cross MedicareRx Value (S5715-001)

levomilnacipran hydrochloride

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$176.77
Patient pays / month, after deductible
$552.42
Patient pays / month, before the $615.00 deductible
$530.32
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 120 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $552.42 for a month. Other covered strengths are listed below.

All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$176.7730 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$177.4930 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$179.0730 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$177.6230 per 30 days
FETZIMA Kit4$179.6528 per 28 days

Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5715-001